Published in

BMJ Publishing Group, Gut, 4(54), p. 479-487, 2005

DOI: 10.1136/gut.2004.044370

Elsevier, Year Book of Gastroenterology, (2006), p. 160-161

DOI: 10.1016/s0739-5930(08)70357-x

Links

Tools

Export citation

Search in Google Scholar

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss

Journal article published in 2005 by P. Obrist, A. M. Wolf, H. Tilg, O. Ludwiczek, A. Kaser, B. Enrich, M. Gabriel, A. R. Moschen ORCID, G. R. Lichtenstein
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Background and aims: A substantial proportion of patients with inflammatory bowel disease (IBD) develops osteopenia and osteoporosis in the course of disease. Recent data from a mouse model of colitis suggest that the receptor activator of nuclear factor kappa B (RANKL)/osteoprotegerin (OPG) system may be responsible for bone loss.